Medical Professional Publications

Tissue Engineered Intestine Technology Developed by Dr. Gail Besner Attracts Funding

Earlier this month, Nanofiber Solutions, an Ohio-based start-up company housed in the TechColumbus incubator, received a $100,000 grant to further develop the tissue engineered intestine technology developed by Dr. Besner.

Ohio Third Frontier provides funding to Ohio-based companies, universities, nonprofit research institutions and other organizations to create new technology-based products, companies, industries and jobs. The Technology Validation and Start-up Fund supports Ohio start-up companies that license technologies developed at eligible Ohio institutions.

Dr. Besner’s lab and Nanofiber Solutions are collaborating to develop tissue scaffolds for gastrointestinal conditions such as short bowel syndrome (SBS). SBS is a disease that affects newborns, children and adults with only limited treatment options. Currently, there is no cure for SBS. The joint efforts of Dr. Besner and Nanofiber Solutions could, for the first time, offer a comprehensive approach to designing new intestines for the treatment of SBS. This highly innovative technology has enormous clinical applicability that could revolutionize the care of patients with SBS.

In addition to the Ohio Third Frontier award, Dr. Besner won the Technology Development Fund (TDF) offered by the Office of Technology Commercialization. She was awarded $50,000 to further her tissue engineered intestine work.

The TDF provides pre-commercial development support for fast-track proof of concept development/validation work in support of technology commercialization. There are two award cycles per year with up to $50,000 being given per award cycle to either one awardee or multiple awardees.  

The deadline for the current award cycle is Tuesday, October 1, 2013.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000